UBC Library Holdings Information

Title:[Drug information (Malone)]
Drug information : a guide for pharmacists / editors, Patrick M. Malone, Meghan J. Malone, and Sharon K. Park.

Other Contributors/Collections:Malone, Patrick M., 1954- editor.
Malone, Meghan J., editor.
Park, Sharon K., editor.

Published/Created:New York, NY : McGraw-Hill Education, [2018]
©2018

Holdings

Holdings Record Display

Location:BMB LIBRARY (VGH) stacksWhere is this?
Call Number: QV737.1 .D794 2018
Number of Items:1
Status:Available

Location:WOODWARD LIBRARY stacksWhere is this?
Call Number: QV737.1 .D794 2018
Number of Items:1
Status:c.1 On loan - Due on 06-10-2024

Library of Congress Subjects:Pharmacy--Information services.
Drugs.

Medical Subjects: Drug Information Services.
Pharmacy Administration--methods.

Edition:Sixth edition.

Description:xxv, 1,430 pages : Illustrations ; 23 cm

Notes:Includes bibliographical references and index.

ISBN:9781259837975 paperback
1259837971 paperback

Contents:Machine generated contents note: Introduction / Dianne May / J. Russell May
Beginning / Dianne May / J. Russell May
Evolution / Dianne May / J. Russell May
Opportunities in Drug Information Specialty Practice / Dianne May / J. Russell May
Summary and Direction for the Future / Dianne May / J. Russell May
Self-Assessment Questions / Dianne May / J. Russell May
Introduction / Joseph K. Jordan / Amy Heck Sheehan
Steps for Answering a Question / Joseph K. Jordan / Amy Heck Sheehan
Formulating the Response / Joseph K. Jordan / Amy Heck Sheehan
Conclusion / Joseph K. Jordan / Amy Heck Sheehan
Self-Assessment Questions / Joseph K. Jordan / Amy Heck Sheehan
Introduction / Sharon K. Park / Kelly M. Shields
Types of Biomedical Resources / Sharon K. Park / Kelly M. Shields
Tertiary Resources / Sharon K. Park / Kelly M. Shields
Secondary Resources / Sharon K. Park / Kelly M. Shields
Primary Resources / Sharon K. Park / Kelly M. Shields
Alternative Resources / Sharon K. Park / Kelly M. Shields
Conclusion / Sharon K. Park / Kelly M. Shields
Self-Assessment Questions / Sharon K. Park / Kelly M. Shields
Introduction / Maisha Kelly Freeman / Rachel M. Slaton / Peter J. Hughes / Michael Kendrach
Biomedical/Pharmacy Literature / Michael Kendrach / Maisha Kelly Freeman / Rachel M. Slaton / Peter J. Hughes
Approach to Evaluating Research Studies (True Experiments) / Maisha Kelly Freeman / Rachel M. Slaton / Peter J. Hughes / Michael Kendrach
Conclusion / Maisha Kelly Freeman / Rachel M. Slaton / Peter J. Hughes / Michael Kendrach
Self-Assessment Questions / Maisha Kelly Freeman / Rachel M. Slaton / Peter J. Hughes / Michael Kendrach
Introduction / Cydney E. McQueen / Patrick J. Bryant
Beyond the Basic Controlled Trial / Cydney E. McQueen / Patrick J. Bryant
N-of-1 Trials / Cydney E. McQueen / Patrick J. Bryant
Adaptive Clinical Trials / Cydney E. McQueen / Patrick J. Bryant
Stability Studies/In Vitro Studies / Cydney E. McQueen / Patrick J. Bryant
Bioequivalence Trials / Cydney E. McQueen / Patrick J. Bryant
Programmatic Research / Cydney E. McQueen / Patrick J. Bryant
Observational Study Design / Cydney E. McQueen / Patrick J. Bryant
Reports Without Control Group / Cydney E. McQueen / Patrick J. Bryant
Survey Research / Cydney E. McQueen / Patrick J. Bryant
Postmarketing Surveillance Studies / Cydney E. McQueen / Patrick J. Bryant
Review Articles / Cydney E. McQueen / Patrick J. Bryant
Practice Guidelines / Cydney E. McQueen / Patrick J. Bryant
Health Outcomes Research / Cydney E. McQueen / Patrick J. Bryant
Dietary Supplement Medical Literature / Cydney E. McQueen / Patrick J. Bryant
Getting to a Clinical Decision / Cydney E. McQueen / Patrick J. Bryant
Conclusion / Cydney E. McQueen / Patrick J. Bryant
Self-Assessment Questions / Cydney E. McQueen / Patrick J. Bryant
Abbreviations / Cydney E. McQueen / Patrick J. Bryant
Acknowledgments / Cydney E. McQueen / Patrick J. Bryant
Introduction / Ryan W. Walters
Populations and Sampling / Ryan W. Walters
Variables and the Measurement of Data / Ryan W. Walters
Descriptive Statistics / Ryan W. Walters
Common Probability Distributions / Ryan W. Walters
Epidemiological Statistics / Ryan W. Walters
Types of Study Design / Ryan W. Walters
Design and Analysis of Clinical Trials / Ryan W. Walters
Statistical Inference / Ryan W. Walters
Selecting the Appropriate Statistical Test / Ryan W. Walters
Introduction to Common Statistical Tests / Ryan W. Walters
Conclusion / Ryan W. Walters
Self-Assessment Questions / Ryan W. Walters
Introduction / Karen L. Rascati / James P. Wilson
Pharmacoeconomics: What Is It and Why Do It? / James P. Wilson / Karen L. Rascati
Relationships of Pharmacoeconomics to Outcomes Research / James P. Wilson / Karen L. Rascati
Models of Pharmacoeconomic Analysis / James P. Wilson / Karen L. Rascati
Assessment of Costs / Karen L. Rascati / James P. Wilson
Assessment of Outcomes / Karen L. Rascati / James P. Wilson
Performing an Economic Analysis / James P. Wilson / Karen L. Rascati
What Is Decision Analysis? / James P. Wilson / Karen L. Rascati
Steps in Reviewing Published Literature / Karen L. Rascati / James P. Wilson
Selected Pharmacoeconomic Websites / James P. Wilson / Karen L. Rascati
Conclusion / James P. Wilson / Karen L. Rascati
Self-Assessment Questions / Karen L. Rascati / James P. Wilson
Introduction / Jeanine P. Abrons / Kevin G. Moores
Evidence-Based Medicine and Clinical Practice Guidelines / Jeanine P. Abrons / Kevin G. Moores
Guideline Development Methods / Jeanine P. Abrons / Kevin G. Moores
Guideline Evaluation Tools / Kevin G. Moores / Jeanine P. Abrons
Implementation of Clinical Practice Guidelines / Kevin G. Moores / Jeanine P. Abrons
Sources of Clinical Practice Guidelines / Kevin G. Moores / Jeanine P. Abrons
Conclusion / Jeanine P. Abrons / Kevin G. Moores
Self-Assessment Questions / Kevin G. Moores / Jeanine P. Abrons
Introduction / Benjamin A. Witt
Conducting the Journal Club / Benjamin A. Witt
Preparing the Presentation / Benjamin A. Witt
Conclusion / Benjamin A. Witt
Self-Assessment Questions / Benjamin A. Witt
Introduction / Martha M. Rumore
Tort Law / Martha M. Rumore
Defenses to Negligence and Malpractice Protection / Martha M. Rumore
Labeling and Advertising / Martha M. Rumore
Direct-to-Consumer (DTC) Drug Information / Martha M. Rumore
Off-Label Use and Informed Consent / Martha M. Rumore
Liability Concerns for Internet/Social Media Information / Martha M. Rumore
Fraud and Abuse / Martha M. Rumore
Intellectual Property Rights / Martha M. Rumore
Privacy / Martha M. Rumore
Industry Support for Educational Activities / Martha M. Rumore
Conclusion / Martha M. Rumore
Self-Assessment Questions / Martha M. Rumore
Introduction / Elyse A. MacDonald / Linda K Ohri
Basics of Ethics Analysis / Linda K Ohri / Elyse A. MacDonald
Resources for Use by Professionals Seeking to Learn More about Medical Ethics, as Applied to Issues Involving Provision of Drug Information / Elyse A. MacDonald / Linda K Ohri
Structures That Support Ethical Decision Making / Elyse A. MacDonald / Linda K Ohri
Conclusion / Elyse A. MacDonald / Linda K Ohri
Self-Assessment Questions / Linda K Ohri / Elyse A. MacDonald
Introduction / Meghan J. Malone / Patrick M. Malone
Steps in Writing / Patrick M. Malone / Meghan J. Malone
Specific Documents / Patrick M. Malone / Meghan J. Malone
Conclusion / Meghan J. Malone / Patrick M. Malone
Self-Assessment Questions / Patrick M. Malone / Meghan J. Malone
Introduction / Indrani Kar / Mark A. Malesker / Patrick M. Malone / Jason E. Glowczewski / Devin J. Fox
Organizational Background / Patrick M. Malone / Mark A. Malesker / Indrani Kar / Devin J. Fox / Jason E. Glowczewski
Pharmacy Support of the P&T Committee / Jason E. Glowczewski / Indrani Kar / Mark A. Malesker / Patrick M. Malone / Devin J. Fox
P&T Committee Meeting / Devin J. Fox / Patrick M. Malone / Mark A. Malesker / Indrani Kar / Jason E. Glowczewski
P&T Committee Functions / Indrani Kar / Mark A. Malesker / Patrick M. Malone / Jason E. Glowczewski / Devin J. Fox
Communication Within an Organization / Mark A. Malesker / Patrick M. Malone / Indrani Kar / Devin J. Fox / Jason E. Glowczewski
Conclusion / Patrick M. Malone / Mark A. Malesker / Jason E. Glowczewski / Indrani Kar / Devin J. Fox
Study Questions / Mark A. Malesker / Patrick M. Malone / Indrani Kar / Devin J. Fox / Jason E. Glowczewski
Self-Assessment Questions / Mark A. Malesker / Patrick M. Malone / Indrani Kar / Jason E. Glowczewski / Devin J. Fox
Acknowledgment / Mark A. Malesker / Patrick M. Malone / Indrani Kar / Devin J. Fox / Jason E. Glowczewski
Introduction / Devin J. Fox / Jason E. Glowczewski / Indrani Kar / Mark A. Malesker / Patrick M. Malone
Conclusion / Devin J. Fox / Patrick M. Malone / Jason E. Glowczewski / Indrani Kar / Mark A. Malesker
Self-Assessment Questions / Devin J. Fox / Jason E. Glowczewski / Indrani Kar / Patrick M. Malone / Mark A. Malesker
Acknowledgment / Jason E. Glowczewski / Indrani Kar / Mark A. Malesker / Patrick M. Malone / Devin J. Fox
Introduction / Erin R. Fox
Drug Shortages / Erin R. Fox
Counterfeit Drugs / Erin R. Fox
Conclusion / Erin R. Fox
Self-Assessment Questions / Erin R. Fox
Introduction / Jennifer K. Thomas / David P. Nau
Changing Environment for Health Care Quality / Jennifer K. Thomas / David P. Nau
Purpose of Measuring Quality / David P. Nau / Jennifer K. Thomas
Quality Measures / Jennifer K. Thomas / David P. Nau
Quality Improvement / Jennifer K. Thomas / David P. Nau
Quality in Drug Information / Jennifer K. Thomas / David P. Nau
Publication of Quality Improvement Studies / David P. Nau / Jennifer K. Thomas
Conclusion / Jennifer K. Thomas / David P. Nau
Self-Assessment Questions / David P. Nau / Jennifer K. Thomas
Introduction / Kelly Besco
Impact of Adverse Drug Reactions / Kelly Besco
Definitions / Kelly Besco
Causality and Probability of Adverse Drug Reactions / Kelly Besco
Classification of Adverse Drug Reactions / Kelly Besco
Implementing a Program / Kelly Besco
Contents note continued: Role of Technology in Adverse Drug Reactions Surveillance / Kelly Besco
Reporting Adverse Drug Reactions / Kelly Besco
Future Approaches to Pharmacovigilance / Kelly Besco
Conclusion / Kelly Besco
Self-Assessment Questions / Kelly Besco
Introduction / Kathryn A. Crea
Definitions: Medication Errors, Adverse Drug Events, and Adverse Drug Reactions / Kathryn A. Crea
Impact of Errors on Patients and Health Care Systems / Kathryn A. Crea
Identification and Reporting of Medication Errors and Adverse Drug Events / Kathryn A. Crea
Classification of Error Types / Kathryn A. Crea
Classifying Patient Outcomes / Kathryn A. Crea
National Reporting / Kathryn A. Crea
Managing an Event Reporting System / Kathryn A. Crea
Types of Safety Event Analysis / Kathryn A. Crea
To Err Is Human / Kathryn A. Crea
System Error / Kathryn A. Crea
Just Culture-Not Shame and Blame / Kathryn A. Crea
Risk Factors for Errors and Events / Kathryn A. Crea
Health Professions Education / Kathryn A. Crea
Best Practices for Error Prevention / Kathryn A. Crea
Other Principles of Error Management / Kathryn A. Crea
Putting It All Together / Kathryn A. Crea
Conclusion: Safety as a Priority / Kathryn A. Crea
Self-Assessment Questions / Kathryn A. Crea
Introduction / Gregory Heindel / Sabrina W. Cole / Conor Hanrahan
Regulatory Considerations / Sabrina W. Cole / Gregory Heindel / Conor Hanrahan
Practice Document Design and Organization / Sabrina W. Cole / Gregory Heindel / Conor Hanrahan
Factors Influencing Practice Document Development / Sabrina W. Cole / Gregory Heindel / Conor Hanrahan
Systematic Method for Practice Document Development and Maintenance / Sabrina W. Cole / Gregory Heindel / Conor Hanrahan
Conclusion / Sabrina W. Cole / Gregory Heindel / Conor Hanrahan
Self-Assessment Questions / Sabrina W. Cole / Gregory Heindel / Conor Hanrahan
Introduction / Sabrina W. Cole / Candice Burns Wood / Conor Hanrahan
Projects, Programs, and Portfolios / Sabrina W. Cole / Conor Hanrahan / Candice Burns Wood
Selecting Projects / Candice Burns Wood / Conor Hanrahan / Sabrina W. Cole
Initiating a Project / Sabrina W. Cole / Conor Hanrahan / Candice Burns Wood
Planning a Project / Candice Burns Wood / Conor Hanrahan / Sabrina W. Cole
Executing a Project / Candice Burns Wood / Conor Hanrahan / Sabrina W. Cole
Monitoring and Controlling a Project / Conor Hanrahan / Candice Burns Wood / Sabrina W. Cole
Closing a Project / Conor Hanrahan / Sabrina W. Cole / Candice Burns Wood
Conclusion / Conor Hanrahan / Sabrina W. Cole / Candice Burns Wood
Self-Assessment Questions / Conor Hanrahan / Sabrina W. Cole / Candice Burns Wood
Introduction / Bambi Grilley
Definitions / Bambi Grilley
History of Drug Development Regulation in the United States / Bambi Grilley
Drug Approval Process / Bambi Grilley
Orphan Drug Act / Bambi Grilley
Institutional Review Board/Institutional Ethics Committee / Bambi Grilley
Role of the Health Care Professional / Bambi Grilley
Conclusion / Bambi Grilley
Self-Assessment Questions / Bambi Grilley
Introduction / Bhavini T. Parikh
Opportunities for Health Professionals within Industry / Bhavini T. Parikh
Regulation of Health Professionals in Industry / Bhavini T. Parikh
Code on Interactions with Health Care Professionals / Bhavini T. Parikh
Fulfillment of MIRs / Bhavini T. Parikh
AE Reporting / Bhavini T. Parikh
Staying Connected with Pharmaceutical Industry / Bhavini T. Parikh
Anatomy of DHHS and FDA / Bhavini T. Parikh
Division of Drug Information / Bhavini T. Parikh
Opportunities within the FDA / Bhavini T. Parikh
Conclusion / Bhavini T. Parikh
Self-Assessment Questions / Bhavini T. Parikh
Introduction / Genevieve Lynn Ness / Robert D. Beckett
Ethical Criteria for Medicinal Drug Promotion / Genevieve Lynn Ness / Robert D. Beckett
Direct-to-Consumer Advertising (DTCA) / Genevieve Lynn Ness / Robert D. Beckett
Promotions to Health Care Professionals / Genevieve Lynn Ness / Robert D. Beckett
Conclusion / Genevieve Lynn Ness / Robert D. Beckett
Self-Assessment Questions / Genevieve Lynn Ness / Robert D. Beckett
Introduction / Suzanne M. Surowiec
Providing Drug Information in the Ambulatory Care Setting / Suzanne M. Surowiec
Drug Information Responsibilities in Ambulatory Care / Suzanne M. Surowiec
Conclusion / Suzanne M. Surowiec
Self-Assessment Questions / Suzanne M. Surowiec
Introduction / Heather A. Pace / Morgan L. Sperry
Pharmacists as Drug Information Providers / Heather A. Pace / Morgan L. Sperry
Patient Sources of Drug Information / Heather A. Pace / Morgan L. Sperry
New Model of Drug Information / Heather A. Pace / Morgan L. Sperry
Conclusion / Heather A. Pace / Morgan L. Sperry
Self-Assessment Questions / Heather A. Pace / Morgan L. Sperry
Introduction / Brent I. Fox / Joshua C. Hollingsworth
Medication Use Process / Brent I. Fox / Joshua C. Hollingsworth
Pharmacy Informatics / Brent I. Fox / Joshua C. Hollingsworth
Order Entry (Prescribing Stage) / Brent I. Fox / Joshua C. Hollingsworth
Order Verification (Transcribing Stage) / Brent I. Fox / Joshua C. Hollingsworth
Dispensing / Brent I. Fox / Joshua C. Hollingsworth
Administration / Brent I. Fox / Joshua C. Hollingsworth
Monitoring / Brent I. Fox / Joshua C. Hollingsworth
Future: Informatics in the U.S. Health Care System / Brent I. Fox / Joshua C. Hollingsworth
Conclusion / Brent I. Fox / Joshua C. Hollingsworth
Self-Assessment Questions / Joshua C. Hollingsworth / Brent I. Fox
Introduction / Michelle W. McCarthy
Drug Information in Pharmacy Curriculum / Michelle W. McCarthy
Postgraduate Training in Drug Information / Michelle W. McCarthy
Conclusion / Michelle W. McCarthy
Self-Assessment Questions / Michelle W. McCarthy
Appendix 2-1 Example of Drug Information Consult Documentation Form / Michelle W. McCarthy
Appendix 2-2 Standard Questions for Obtaining Background Information from Requestors / Michelle W. McCarthy
Appendix 3-1 Performing a PubMed Search / Michelle W. McCarthy
Appendix 3-2 Selected Primary Literatures Sources / Michelle W. McCarthy
Appendix 4-1 Drug Literature Assessment Questions for Clinical Trials / Michelle W. McCarthy
Appendix 5-1 Beyond the Basics: Questions to Consider for Critique of Primary Literature / Michelle W. McCarthy
Appendix 8-1 Grade Evidence Profile: Antibiotics for Children with Acute Otitis Media / Michelle W. McCarthy
Appendix 11-1 Code of Ethics for Pharmacists / Michelle W. McCarthy
Appendix 12-1 Question Example / Michelle W. McCarthy
Appendix 12-2 Abstracts / Michelle W. McCarthy
Appendix 12-3 Bibliography / Michelle W. McCarthy
Appendix 13-1 Pharmacy and Therapeutics Committee Procedure / Michelle W. McCarthy
Appendix 13-2 Formulary Request Form / Michelle W. McCarthy
Appendix 13-3 P&T Committee Meeting Attributes / Michelle W. McCarthy
Appendix 13-4 Example P&T Committee Minutes / Michelle W. McCarthy
Appendix 13-5 Chairperson Skills / Michelle W. McCarthy
Appendix 13-6 Conflict of Interest Declaration / Michelle W. McCarthy
Appendix 14-1 Format for Drug Monograph / Michelle W. McCarthy
Appendix 14-2 Example Drug Monograph / Michelle W. McCarthy
Appendix 16-1 Tools Used in Quality Assurance / Michelle W. McCarthy
Appendix 16-2 Example of Criteria and Request for Approval / Michelle W. McCarthy
Appendix 16-3 Example of MUE Results / Michelle W. McCarthy
Appendix 16-4 Evaluation Form for Drug Information Response / Michelle W. McCarthy
Appendix 17-1 Kramer Questionnaire / Michelle W. McCarthy
Appendix 17-2 Naranjo Algorithm / Michelle W. McCarthy
Appendix 17-3 Jones Algorithm / Michelle W. McCarthy
Appendix 17-4 Liverpool ADR Causality Assessment Tool / Michelle W. McCarthy
Appendix 17-5 MedWatch Form / Michelle W. McCarthy
Appendix 19-1 Policy Example: High-Alert Medications / Michelle W. McCarthy
Appendix 20-1 Example of a Project Charter / Michelle W. McCarthy
Appendix 20-2 Stakeholder Matrix-IV Compounding Software Project / Michelle W. McCarthy
Appendix 20-3 Example PESTLE Analysis-IV Compounding Software Project / Michelle W. McCarthy
Appendix 20-4 Example Work Breakdown Structure (WBS)-IV Compounding Software Project / Michelle W. McCarthy
Appendix 21-1 Investigational New Drug Application / Michelle W. McCarthy
Appendix 21-2 Statement of Investigator / Michelle W. McCarthy
Appendix 21-3 Protocol Medication Economic Analysis / Michelle W. McCarthy
Appendix 21-4 Investigational Drug Accountability Record / Michelle W. McCarthy
Appendix 22-1 Response Letter Drug A-Incidence of Yellow Stripes / Michelle W. McCarthy.

Holdings Information

Action Navigation

Action Box More Info Navigation

Action Box

Bibliographic Record Display

Holdings

Holdings Record Display